Page 26 - 2021
P. 26

Ph.D.
                                                                                     (Pharmacy)
          FORMULATION, OPTIMIZATION AND CHARACTERIZATION OF
          NANOFORMULATIONS OF AN ANTIBIOTIC

          Ph.D. Scholar : Goswami Nilamgiri Dahyagiri
          Research Supervisor : Dr. Rakesh P. Patel



                                                                                Regi. No.: 16146021004
          Abstract :
          The research work shall emphasize the design, development, and characterization of the
          nanoformulations  of  Nitrofurantoin  (NFT)  by  formulating  solid  lipid  nanoparticles,
          nanostructured lipid carrier, nanosuspension, and nanocrystals for oral drug delivery of
          Nitrofurantoin, a broad-spectrum bactericidal antibiotic.

          The  analytical  method  of  NFT  was  developed  by  HPLC-UV  technique.  Various
          characterization studies like FTIR, DSC, XRD were performed to check the compatibility
          study with drug and excipients. SLN is prepared by hot homogenization Process using
          glyceryl  monostearate  and  Glyceryl  behenate  along  with  poloxamer  188  and  purified
          water. A nanostructured lipid carrier was prepared by using glyceryl monostearate and
          miglyol 812 along with poloxamer 188 and purified water. Nanosuspension of NFT was
          prepared by a high speed homogenization process using HPMC E3, poloxamer 188, and
          purified  water.  Nanocrystals  were  formulated  by  using  dichloromethane  and  HPMC  E3
          along with poloxamer 188 and purified water. The preliminary formulation of solid lipid
          nanoparticles,  nanostructured  lipid  carriers,  nanosuspension,  and  nanocrystals  was
          tested  for  zeta  potential,  polydispersity  index,  and  particle  size.  The  formulations  were
          optimized following 32 factorial designs. Particle size, polydispersity index, zeta potential,
          and entrapment efficiency were evaluated for the confirmation of nanoformulations. The
          surface morphology of final formulations was confirmed with SEM and TEM studies. In-
          vitro  releases  were  studies  of  the  above  nanoformulations.  Stability  studies  of  final
          nanoformulations were checked for 6 months as per the ICH guidelines. Finally, In-vivo
          studies  of  these  solid  lipid  nanoparticles,  nanostructured  lipid  carrier,  nanosuspension,
          and nanocrystals were carried out for bioavailability study and compared with marketed
          formulations.  From  the  development,  optimization,  and  characterization  of  NFT  loaded
          nanoformulations,  it  is  concluded  that  solid  lipid  nanoparticles,  nanostructured  lipid
          carrier, nanosuspension, and nanocrystals were showed satisfactory outcomes for drug
          release profile and bioavailability.  Among all the developed nanoformulations solid lipid
          nanoparticles of NFT found a better release profile with increment in bioavailability.

          Key  words:  Nitrofurantoin,  Glyceryl  Monostearate,  Glyceryl  Behenate,  NFT,  Miglyol  812,
          Solid Lipid Nanoparticles, Nanostructured Lipid Carriers,  Nanocrystals,  Nanosuspension

                                                                                             05
   21   22   23   24   25   26   27   28   29   30   31